Pages that link to "Q39139601"
Jump to navigation
Jump to search
The following pages link to Small Molecules That Sabotage Bacterial Virulence (Q39139601):
Displaying 28 items.
- An Entirely Solid Phase Peptide Synthesis-Based Strategy for Synthesis of Gelatinase Biosynthesis-Activating Pheromone (GBAP) Analogue Libraries: Investigating the Structure-Activity Relationships of the Enterococcus faecalis Quorum Sensing Signal (Q36394865) (← links)
- A Red Blood Cell Membrane-Camouflaged Nanoparticle Counteracts Streptolysin O-Mediated Virulence Phenotypes of Invasive Group A Streptococcus (Q40109133) (← links)
- The Accidental Orthodoxy of Drs. Mueller and Hinton (Q41348561) (← links)
- Targeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics (Q46325130) (← links)
- Structure-Function Relationship of Aminopeptidase P from Pseudomonas aeruginosa. (Q47233305) (← links)
- Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases (Q47769000) (← links)
- How can naturally occurring fatty acids neutralize Listeria? (Q47916010) (← links)
- CLIQ-BID: A method to quantify bacteria-induced damage to eukaryotic cells by automated live-imaging of bright nuclei (Q50114639) (← links)
- Genetic and metabolic regulation of Mycobacterium tuberculosis acid growth arrest. (Q54259397) (← links)
- Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition. (Q54980058) (← links)
- Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo (Q57095370) (← links)
- From General to Specific: Can Pseudomonas Primary Metabolism Be Exploited for Narrow-Spectrum Antibiotics? (Q57170365) (← links)
- Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on and Studies (Q58585935) (← links)
- Molecules that Inhibit Bacterial Resistance Enzymes (Q61455372) (← links)
- Small-molecule inhibitor of HlyU attenuates virulence of Vibrio species (Q64100368) (← links)
- Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in (Q64107158) (← links)
- Inhibiting DosRST as a new approach to tuberculosis therapy (Q89692975) (← links)
- On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome (Q90170341) (← links)
- Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients (Q90265508) (← links)
- Inhibiting Mycobacterium tuberculosis DosRST Signaling by Targeting Response Regulator DNA Binding and Sensor Kinase Heme (Q90304497) (← links)
- Structure-based Druggability Assessment of Anti-virulence Targets from Pseudomonas aeruginosa (Q91633159) (← links)
- Evaluation of mouse enteroids as a model for Lawsonia intracellularis infection (Q92029982) (← links)
- A high-throughput system to identify inhibitors of Candidatus Liberibacter asiaticus transcription regulators (Q92709037) (← links)
- An in situ high-throughput screen identifies inhibitors of intracellular Burkholderia pseudomallei with therapeutic efficacy (Q92796887) (← links)
- Curcumin Attenuates the Pathogenicity of Entamoeba histolytica by Regulating the Expression of Virulence Factors in an Ex-Vivo Model Infection (Q92823139) (← links)
- Probing the evolutionary robustness of two repurposed drugs targeting iron uptake in Pseudomonas aeruginosa (Q93227330) (← links)
- An ecosystem framework for understanding and treating disease (Q93384099) (← links)
- Secondary Bacterial Infections in Patients With Viral Pneumonia (Q98771809) (← links)